CD40 ligand is a critical effector of Epstein-Barr virus in host cell survival and transformation

46Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

Abstract

Epstein-Barr virus (EBV), implicated in numerous human diseases, including lymphoid malignancies, persistently infects peripheral B cells and transforms them into lymphoblastoid cell lines. Here we found that EBV equally infected B cells from patients with X-linked hyper IgM syndrome and those from healthy donors; however, it hardly transformed X-linked hyper IgM syndrome B cells, because of the dysfunctional gene of CD40 ligand (CD40L) of the patients. Unlike CD40, CD40L is not usually expressed on B cells. However, we found that EBV infection of normal B cells induced CD40L expression as a critical effector in host cell transformation and survival. Moreover, chronic active EBV infection of peripheral T cells, implicated in T cell malignancies, was associated with ectopic expression of CD40, and, in Jurkat T cells, EBV infection induced CD40 expression. These results suggest that EBV infection induces CD40L/CD40 signaling in host cells, which appears to play an essential role in its persistent infection and malignancies of lymphocytes.

Cite

CITATION STYLE

APA

Imadome, K. I., Shirakata, M., Shimizu, N., Nonoyama, S., & Yamanashi, Y. (2003). CD40 ligand is a critical effector of Epstein-Barr virus in host cell survival and transformation. Proceedings of the National Academy of Sciences of the United States of America, 100(13), 7836–7840. https://doi.org/10.1073/pnas.1231363100

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free